Malegra FXT (sildenafil + fluoxetine)
Malegra FXT is described as sildenafil 100 mg plus fluoxetine 40 mg, attributed to Sunrise Remedies.
- Active ingredient
- sildenafil + fluoxetine
- Formulation
- Oral tablet
- Company in catalogue
- Sunrise Remedies Pvt Ltd
Malegra FXT is described as sildenafil 100 mg plus fluoxetine 40 mg, attributed to Sunrise Remedies. The corresponding Malegra DXT record contains duloxetine instead, despite the similar family name.
What distinguishes this product
Fluoxetine is an antidepressant with its own interaction profile. Its presence changes the medicine review required for this product; sildenafil ingredient guidance alone cannot establish suitable use of the combination.
Product record
- Record type
- Indian branded generic
- Treatment area in this directory
- Erectile dysfunction (ED)
- Active ingredient
- sildenafilfluoxetine
- Formulation in the cited record
- Oral tablet
- Source-listed strengths
- Sildenafil 100 mg + Fluoxetine 40 mg
- Company in the cited record
- Sunrise Remedies Pvt Ltd (Company attributed by the source catalogue)
- Manufacturing information
- A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
- Market evidence
- Global reference; exact market authorization not established by this catalogue import
- Storage reported by source
- Store below 30°C Check the supplied leaflet for the exact presentation.
- Catalogue reviewed
Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.
Component amounts in the source
- sildenafil: 100 mg
- fluoxetine: 40 mg
Ingredient references
These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.
How the ingredients fit treatment
Sildenafil supports the erection response to sexual stimulation by inhibiting PDE5. It is used before sexual activity in ED treatment; it is not a libido stimulant. Food can affect the response, so use the instructions for the prescribed presentation.
Ingredient guidance and safe use
Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.
Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.
Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.
A fixed combination needs assessment of every ingredient and their use together. Approval of either ingredient separately does not establish that the combination is suitable. Do not add another ED medicine to it without medical advice.
Tell the prescriber about antidepressants and other medicines affecting serotonin. Do not start, stop or change an existing antidepressant prescription to fit an ED combination product.
Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record
Related product records
- Viagra — sildenafil
- Caverta — sildenafil
- Cenforce — sildenafil
- Cenforce Professional — sildenafil

